Johnson & Johnson announces it will split into two companies
The pharmaceutical and medical device business will keep the J&J name while the division that sells Band-Aids and Listerine will go it alone.
Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine from its medical device and prescription drug business.
The company said Friday that the division selling prescription drugs and medical devices will keep Johnson & Johnson as its name.
The new consumer health company will house brands including Neutrogena, Aveeno, Tylenol, Listerine, Johnson’s and Band-Aid. A name was not disclosed for the new company.
Details are sparse, but the company expect the split to occur in the next two years.